Research output per year
Research output per year
Personal profile
Research interests
Cancer Cell Motility and Imaging
Research interests (short)
Click here for the Ng group webpage
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Tony Ng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
LYVE-1 + macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer
Anstee, J. E., Feehan, K. T., Opzoomer, J. W., Dean, I., Muller, H. P., Bahri, M., Cheung, T. S., Liakath-Ali, K., Liu, Z., Choy, D., Caron, J., Sosnowska, D., Beatson, R., Muliaditan, T., An, Z., Gillett, C. E., Lan, G., Zou, X., Watt, F. M., Ng, T., & 5 others, 11 Sept 2023, In: Developmental Cell. 58, 17, p. 1548-1561.e10Research output: Contribution to journal › Article › peer-review
Open Access -
HER2 mediates PSMA/mGluR1-driven resistance to the DS-7423 dual 2 PI3K/mTOR inhibitor in PTEN wild-type prostate cancer models: PTEN-wt PCa overcomes PI3K inhibition via mGluR1 signaling
Gómez, V., Galazi, M., Weitsman, G., Monypenny of Pitmilly, J., Al-Salemee, F., Barber, P., Ng, K., Beatson, R., Szokol, B., Orfi, L., Mullen, G., Vanhaesebroeck, B., Chowdhury, S., Leung, H. Y. & Ng, T., 19 Jan 2022, (Accepted/In press) In: MOLECULAR CANCER THERAPEUTICS.Research output: Contribution to journal › Article › peer-review
-
HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models
Gómez, V., Galazi, M., Weitsman, G., Monypenny, J., Al-Salemee, F., Barber, P. R., Ng, K., Beatson, R., Szokol, B., Orfi, L., Mullen, G., Vanhaesebroeck, B., Chowdhury, S., Leung, H. Y. & Ng, T., 1 Apr 2022, In: Molecular Cancer Therapeutics. 21, 4, p. 667-676 10 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans
Vicencio Bustamante, J., Evans, R., Green, R., An, Z., Deng, J., Treacy, C., Mustapha, R., Monypenny of Pitmilly, J., Costoya, C., Lawler, K., Ng, K., Desouza, K., Coban, O., Gomez, V., Clancy, J., Chen, SH., Chalk, A., Wong, F., Gordon, P., Savage, C., & 20 others, 28 Mar 2022, In: Cell Death & Disease. 13, 3, 274 .Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Citations (Scopus)55 Downloads (Pure) -
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development
Barber, P. R., Mustapha, R., Flores-Borja, F., Alfano, G., Ng, K., Weitsman, G., Dolcetti, L., Suwaidan, A. A., Wong, F., Vicencio, J. M., Galazi, M., Opzoomer, J. W., Arnold, J. N., Thavaraj, S., Kordasti, S., Doyle, J., Greenberg, J., Dillon, M. T., Harrington, K. J., Forster, M., & 2 others, Dec 2022, In: eLife. 11, e73288.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)
-
Multi-scale mechanochemical signals regulating cancer cell survival and invasive potential
Parsons, M., Ng, T. & Sinkus, R.
1/12/2022 → 30/11/2027
Project: Research
-
CoL: CRUK City of London Centre renewal (COLMC)
Ng, T., Arnold, J., Blower, P., Ciccarelli, F., Dazzi, F., Farzaneh, F., Grigoriadis, A., Hayday, A., Irshad, S., Kong, A., Kordasti, S., Lawrence, T., Mishto, M., Papa, S., Purushotham, A., Quek, L., Ramsay, A., Sarker, D., Sinkus, R., Spicer, J., Witney, T. & academic, A.
1/04/2022 → 31/03/2027
Project: Research
-
Integrated multi-modal tissue state mapping of TNBC progression
Parsons, M., Abbate, V., Ameer-Beg, S., Barber, P., Bergholt, M., Chan, A., Chiappini, C., Cox, S., Gillett, C., Grigoriadis, A., Irshad, S., Karimi, M. M., Ng, T., Ourselin, S., Pinder, S., Purushotham, A., Sinkus, R., Spencer, J. & Stewart, T.
30/09/2021 → 29/09/2024
Project: Research
-
Activities
- 4 Publication peer-review
- 3 Participation in conference
- 2 Types of Business and Community - Work on advisory panel to industry or government or non-government organisation
- 1 Types of External academic engagement - Contribution to the work of national or international committees and working groups
-
More
-
‘The use of fluorescence lifetime imaging to dissect specific protein complexes involved in receptor signal and trafficking: implications for new therapeutic intervention sites in cancer’The 14th International Conference of the International Society of Differentiation. Innsbruck, AUSTRIA
Tony Ng (Speaker)
Oct 2006 → …Activity: Participating in or organising an event › Participation in conference
-
From single cell to the whole proteome - the basis of an Optical Imaging Approach to understand cancer metastasis'. Third International Symposium of the Austrian Proteomics Platform (Seefeld, Tirol, Austria)
Tony Ng (Keynote/plenary speaker)
2006 → …Activity: Participating in or organising an event › Participation in conference
-
EPSRC Peer Review College
Tony Ng (Member)
2006 → 2009Activity: Other › Types of External academic engagement - Membership of peer review panel or committee
-
“The use of advanced (optical) cell imaging to dissect the functional organisation of proteins in cancer cells/tissues”. FASEB Conference (Callaway Gardens Resort, Pine Mountain, GA) on "Thrombospondins and other modulatory adhesion molecules in tissue organisation and homeostasis"
Tony Ng (Keynote/plenary speaker)
Jun 2004 → …Activity: Participating in or organising an event › Participation in conference
-
High Content Biology Meeting (AstraZeneca Opinion leader meeting)
Tony Ng (Member)
2003 → …Activity: Other › Types of Business and Community - Work on advisory panel to industry or government or non-government organisation